Legal & General Group
VOR icon

Legal & General Group’s Vor Biopharma VOR Stock Holding History

Legal & General Group’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-181
Closed -$8.6K – 3514
2024
Q1 		$8.6K Hold
181
– – ﹤0.01% 3232
2023
Q4 		$8.14K Hold
181
– – ﹤0.01% 3264
2023
Q3 		$7.69K Hold
181
– – ﹤0.01% 3316
2023
Q2 		$11.2K Buy
+181
New +$16.5K ﹤0.01% 3298
2022
Q2 		– Sell
-78
Closed -$9K – 3666
2022
Q1 		$9K Hold
78
– – ﹤0.01% 3433
2021
Q4 		$18K Hold
78
– – ﹤0.01% 3312
2021
Q3 		$24K Buy
78
+29
+59% +$8.62K ﹤0.01% 3219
2021
Q2 		$18K Sell
49
-10
-17% -$4.93K ﹤0.01% 3335
2021
Q1 		$51K Buy
+59
New +$49.9K ﹤0.01% 2809

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Legal & General Group's VOR Position: Q2 2024 in Review

Legal & General Group sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 181 shares — an estimated $8.6K sold.

Legal & General Group first reported a position in VOR in Q1 2021 and held it in 9 quarters. The position peaked at $51K in Q1 2021. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • Legal & General Group reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 181 Vor Biopharma shares in Q2 2024, an estimated $8.6K.
  • Legal & General Group first reported a position in Vor Biopharma in Q1 2021 and held it in 9 quarters.
  • Legal & General Group's Vor Biopharma position peaked at $51K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.